Latest Industrial Scale Up News

Strategic Elements Ltd (ASX: SOR) reported meaningful progress in its Energy Ink™ technology and underground mining platform during Q1 2025, while maintaining a robust cash balance and preparing for international collaborations.

First Graphene Limited reported a successful A$2.4 million capital raise alongside promising progress in its PureGRAPH-CEM product trials in the UK and South Africa, while securing key patents and expanding distribution across Asia and South America.

Cosmos Exploration has taken a major step into the global lithium market by signing an exclusive option agreement to acquire EAU Lithium Pty Ltd, unlocking access to Bolivia’s vast lithium resources and pioneering advanced extraction technology.

First Graphene Limited reports a robust December quarter with new patents, expanded distribution networks, and advancing commercial trials, positioning the company on a path to cash breakeven.

Foresta Group Holdings has raised $3.1 million through a convertible note and share placement, while securing exclusive technology licensing and key offtake agreements to propel its flagship New Zealand biomass project.

Cosmos Exploration has secured an exclusive option to acquire EAU Lithium, partnering with Vulcan Energy to deploy cutting-edge Direct Lithium Extraction technology in Bolivia’s lithium-rich salars. This strategic move positions Cosmos at the forefront of sustainable lithium production in the world’s largest lithium resource base.

Parkway Corporate Limited reports a robust December quarter with a 420% revenue increase and key milestones in brine processing technology, positioning itself as a pivotal player in Queensland's CSG industry.

First Graphene Limited has responded to an ASX price query, attributing its recent share price and volume surge to increased buying activity in Germany linked to prior commercial announcements, while reaffirming full compliance with ASX disclosure rules.

Mesoblast has raised A$260 million through a global private placement to fund the US commercial launch of its FDA-approved cell therapy Ryoncil® and accelerate clinical development in chronic low back pain.

Titomic Limited has appointed Jim Simpson as Managing Director, consolidating leadership as the company accelerates its expansion in the US additive manufacturing market.